News

Kaldalón hf. Continues Share Buyback Strategy in 2025

Kaldalón hf. Continues Share Buyback Strategy in 2025

Overview of Kaldalón hf.'s Share Buyback Program

Kaldalón hf. is taking significant strides in its financial management through a share buyback program. As of week 41 in 2025, the company did not acquire any additional shares under this initiative, which was initially announced on Nasdaq Iceland.

Details of the Buyback Program

The current buyback program allows for the purchase of up to 15,000,000 shares, contingent upon a maximum expenditure limit of ISK 350,000,000. This program commenced on July 1, 2025, and will proceed until either the share limit or the spending cap is reached, with the final deadline set for December 31, 2025.

Progress So Far

Kaldalón hf. began the buyback program without any treasury shares. By the end of week 41, the company had successfully acquired 13,877,136 shares, amounting to about 1.28% of the total issued share capital. The total cost incurred for these buybacks stands at ISK 341,820,747.

Regulatory Compliance

The execution of the buyback program is in alignment with the Icelandic Companies Act No. 2/1995 and fits within the framework set by the European Union’s Regulation (EU) No. 596/2014 concerning market abuse. The company is dedicated to maintaining full compliance, ensuring ethical standards in their stock acquisition endeavors.

Importance of Share Buybacks

Share buybacks are often regarded as a sign of confidence in a company's financial health. They provide an opportunity for companies to return capital to shareholders while potentially increasing the share price by reducing the supply of available shares. Kaldalón hf.'s active participation in this buyback program reflects a commitment to maximizing shareholder value.

Looking Ahead

As the buyback program continues through 2025, stakeholders will be keen to observe Kaldalón hf.'s trajectory. The company’s efforts signify its strategic focus on capital management and market position enhancement.

Frequently Asked Questions

What is the purpose of Kaldalón hf.'s share buyback program?

The program is designed to enhance shareholder value by repurchasing shares from the market, which can lead to an increase in share price and improve return on equity.

How many shares is Kaldalón hf. permitted to buy back?

The program allows for a maximum buyback of 15,000,000 shares, depending on the financial limits set within the program.

As of now, how many shares has Kaldalón hf. repurchased?

To date, Kaldalón hf. has repurchased 13,877,136 shares, representing 1.28% of its total issued share capital.

What regulations guide Kaldalón hf.’s buyback program?

The buyback is carried out in accordance with Icelandic law and EU regulations concerning market conduct and share buybacks.

Who can I contact for more information regarding the share buyback?

For additional information, you can reach out to Jón Þór Gunnarsson, CEO of Kaldalón hf., via email at jon.gunnarsson@kaldalon.is.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Socket Mobile Moves Listing from Nasdaq to OTCID

Updated Category News Views 7

When Socket Mobile decided to jump ship from Nasdaq to the OTCID Market, they sure shook things up. We have a company that’s taking a bold leap, moving off the big-time Nasdaq stage to the less glitzy, but arguably more financially forgiving, floors of the OTC Markets. Why Leave Nasdaq? Cost-Cutting for Core Growth Now, above all else, the rationale screams ‘money...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 77

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
Advanced Process Solutions Reshuffles Leadership Amid Growth

Updated Category News Views 131

Clint Johnson Ascends as VP Amidst Strategic Moves Clint Johnson's climb to Vice President of Services and Operations at Advanced Process Solutions (APS) ain't just routine corporate ladder gymnastics—it's a sign of shifting tides. Slapping your buddy’s back after years in the trenches, that kind of camaraderie translates into momentum. The precision manufacturing...

Continue Reading
IBSSC 2026: A New Chapter in Business Education

Updated Category News Views 78

Shifts in Business Education at the IBSSC 2026 Boy, oh boy, Shanghai was buzzing the other week. We’re diving into the heart of the 11th International Business School Shanghai Conference (IBSSC). There's a changing of the guard in how business education is viewed, and it was all happening from October 21 to 23 at the Xuhui campus of Shanghai Jiao Tong University. Global...

Continue Reading
Beta Bionics Faces Class Action Over iLet Device Concerns

Updated Category News Views 69

Securities Fraud Allegations Hit Beta Bionics Here's a fresh one on the market front—Beta Bionics is in hot water, and it's not looking pretty. The ticker NASDAQ:BBNX is swirling in the chaos of a class action lawsuit, thanks to a stock tumble that would make even seasoned traders cringe. What's got investors riled up? The nitty-gritty centers on accusations that the...

Continue Reading
CoCo Expands Bubble Tea Empire: Hungary to Ukraine

Updated Category News Views 72

CoCo's Three-Market Strategy Dive into the world of bubbly enthusiasm: CoCo Bubble Tea is making a splash in Central and Eastern Europe, targeting Hungary, Armenia, and gearing up for Ukraine. No small feat, this move taps straight into the heart of younger consumers who can't get enough of quirky, customizable Asian-inspired drinks. We're not only talking tea—this is a...

Continue Reading
Valmet Grabs Tieto Unit, Aims for Autonomous Leap

Updated Category News Views 71

Valmet Makes a Strategic Move Alright, here's a bold move from Valmet: they've decided to snatch up Tieto’s manufacturing execution system (MES) business. Seems they're gunning for a quick leapfrog into the era of autonomous operations. Now, folks who dabble in the industry know this is akin to adding rocket fuel to their current setup. Valmet seriously aims to...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 24

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Ultrasound Innovations: 2D, 3D, and 4D Explained

Updated Category News Views 24

Diving into the World of Ultrasound Imaging When you're in the trenches of expecting a new family member, the last thing you want is to get bogged down in technical jargon that doesn't make a lick of sense. Enter prenatal ultrasound imaging: 2D, 3D, and 4D. Each of these has a specific role in piecing together the puzzle of fetal development. Now, Erika Lambright, a...

Continue Reading
Archera Raises $15M to Redefine Cloud Commitment Models

Updated Category News Views 0

Rethinking Cloud and AI Contracts A new day in cloud economics has dawned, folks, and it’s shining over Archera, a name you'll want to remember if you're navigating the murky waters of cloud and AI spending. As the world dashes headlong into AI, cloud investments are becoming a game of either overcommitting or missing out on key discounts. Archera's snagged a $15...

Continue Reading

Top 5 Most Recently Viewed Articles

BioMarin Releases Robust Q2 2025 Results and Growth Outlook

Updated Category News Views 287

BioMarin Pharmaceutical Inc. Announces Positive Financial Performance In a recent announcement, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) revealed impressive financial results for the second quarter of 2025. The company achieved total revenues of $825 million, reflecting a year-over-year growth of 16%. This robust increase not only highlights the company's strong...

Continue Reading
Centerspace Sale Faces Scrutiny Amid Investor Concerns

Updated Category News Views 92

Potential Undervaluation Looms Large over Centerspace Sale On a crisp October day, the saga of Centerspace's proposed sale to Independence Realty Trust (NYSE: IRT) is stirring the pot. Charles C. Foti, Jr., Esq., and the law firm Kahn Swick & Foti, LLC are throwing a wrench into the works, questioning the soundness of the whole shebang. The deal, valued at 3.800 shares of...

Continue Reading
Frontier Biotech and GSK Team Up: A Game Changer in Biopharma

Updated Category News Views 166

Big News from the Biopharma World Did you catch the scoop? Frontier Biotechnologies just inked a deal with GSK that's shaking things up in the biotech sphere. They’re talking big bucks—$40 million upfront, plus up to $963 million in milestone potential. That’s a hefty price tag, signaling confidence, or maybe a flash in the pan? Who knows? But what it does say is...

Continue Reading
Toro’s Mower Health Checklist: A Spring Wake-up Call

Updated Category News Views 145

Mower Maintenance Week: Don't Let Engine Failure Ruin Your Spring March is upon us, and if you think you can just roll out your mower and get to it, think again. Toro's launching its Lawn Mower Maintenance Week from March 1–7, 2026, and it's not just fluff. This is your wake-up call to get those blades sharp and those engines healthy. Remember, the last thing you want...

Continue Reading
Market Trends: Insights into Mexico's Stock Performance

Updated Category News Views 317

Overview of Mexico's Stock Market Performance Recently, Mexico's stock market has experienced some fluctuations, with a noticeable decline driven by sectors like Industrials, Consumer Goods & Services, and Consumer Staples. This downturn often mirrors broader economic trends and investor sentiment, which can greatly influence the overall market environment. S&P/BMV IPC...

Continue Reading